Day: March 2, 2026

Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

TORONTO, March 02, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Inc. (“Xanadu”), a global leader in photonic quantum computing, and Crane Harbor Acquisition Corp. (Nasdaq: CHAC) (“Crane Harbor”), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective the companies’ joint registration statement on Form F-4 in connection with their previously announced proposed business combination. This marks a significant milestone in the transaction process and moves Xanadu substantially closer to becoming a publicly traded company. The business combination is expected to close in the first quarter of 2026, subject to the satisfaction of customary closing conditions, including the approval by Crane Harbor and Xanadu shareholders and the listing...

Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

– Planned submission for U.S. Accelerated Approval of z-rostudirsen on track for Q2 2026; potential launch in Q1 2027 – – Positive topline results reported from Phase 1/2 DELIVER trial of z-rostudirsen in exon 51 skip amenable Duchenne muscular dystrophy (DMD); additional long-term data to be presented at MDA – – Completion of enrollment in registrational expansion cohort of Phase 1/2 ACHIEVE trial of z-basivarsen in myotonic dystrophy type 1 (DM1) expected in Q2 2026; Phase 3 trial design to be presented at MDA – – Advancing four development candidates for the potential treatment of DMD amenable to skipping of exons 53, 45, 44, and 55 – – Year-end cash of $1.1 billion; reaffirming expected cash runway into Q1 2028 – WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) — Dyne...

TEGNA Inc. Reports Fourth Quarter and Full-Year 2025 Results

Written by Customer Service on March 2, 2026. Posted in Earnings Releases And Operating Results.

Achieves or exceeds all previously announced full-year 2025 guidance metrics On track to complete proposed acquisition by Nexstar Media Group by the second half of 2026, subject to regulatory approvals and customary closing conditions MCLEAN, Va., March 02, 2026 (GLOBE NEWSWIRE) — TEGNA Inc. (NYSE: TGNA) today announced financial results for the fourth quarter and full-year 2025, ended December 31, 2025. FOURTH QUARTER FINANCIAL HIGHLIGHTS:All Year-Over-Year Comparisons Unless Otherwise Noted:Total company revenue was down 19% from the prior year at $706 million primarily due to lower political advertising revenue, consistent with cyclical even-to-odd year comparisons partially offset by growth in Advertising and Marketing Services (AMS) revenue. Distribution revenue was slightly lower at $358 million due to subscriber declines,...

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 per Share for March 2026

Written by Customer Service on March 2, 2026. Posted in Dividend Reports And Estimates.

HOUSTON, March 02, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.085 per share for March 2026. This distribution is payable to common stockholders on March 31, 2026 (as outlined in the table below). The Company declares and pays distributions monthly. Payment of future distributions is subject to the approval of the Company’s Board of Directors, as well as meeting the covenants on the Company’s debt agreements and the terms of its preferred stock.Record Date / Ex-Date Payment Date Distribution Amount Return of Capital Estimate3/13/26 3/31/26 $0.085 50%(1)(1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the...

Nexxen Announces February 2026 Share Repurchase Program Summary

Written by Customer Service on March 2, 2026. Posted in Public Companies.

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it repurchased 496,981 shares at an average price of $6.02 during February 2026. As of February 28, 2026, Nexxen had 55,720,779 Ordinary Shares outstanding (excluding treasury shares), and approximately $2.0 million remaining under its current share repurchase authorization. As previously disclosed, the Company has received authorization to initiate a new share repurchase program (the “new program”) of up to $40 million, which is scheduled to begin upon completion of its current program. Under the new program, Nexxen will not be obligated to repurchase any specific number of shares, and the program may...

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

Written by Customer Service on March 2, 2026. Posted in Mergers And Acquisitions.

HEMANGEOL® is the only FDA-approved treatment for infantile hemangioma HEMANGEOL will be commercialized by Eton beginning May 1st HEMANGEOL will be distributed through the company’s Eton Cares™ patient support program, which includes a $0 co-pay initiative, to broaden patient access.DEER PARK, Ill., March 02, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced it has in-licensed U.S. commercialization rights to HEMANGEOL® oral solution from Pierre Fabre Medicament Sas (“Pierre Fabre”). HEMANGEOL is an Orphan Drug indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. “As the only treatment for infantile hemangiomas that...

Statkraft AS: Release of fourth quarter results 2025 and annual report for 2025

Written by Customer Service on March 2, 2026. Posted in Public Companies.

Statkraft discloses fourth quarter results 2025 and the annual report for 2025 on Thursday 5 March 2026 at 08:00 a.m. CET. Material will be available on Statkraft’s website https://www.statkraft.com/IR/ and Oslo Stock Exchange’s news service www.newsweb.no. Webcast09:30 a.m. CET: Statkraft presents the results in a webcast at www.statkraft.com. The presentation will be held in English. Contact:Arild Ratikainen, Investor Contact, tlf.: +47 971 74 132, e-mail: arild.ratikainen@statkraft.com

Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone

Written by Customer Service on March 2, 2026. Posted in Public Companies.

JUPITER, Fla. and COPENHAGEN, Denmark, March 02, 2026 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bio-industrial uses, and Inzymes ApS (“Inzymes”), a Denmark-based enzyme company specializing in the development, scale-up, and commercialization of enzymes for sustainable food and beverage applications, today announced the planned 2026 commercialization of recombinant non-animal bovine chymosin, a key enzyme used in cheese production and dairy processing, following the successful completion of final development activities under the companies’ collaboration agreement. Completion of these development activities represents a contractual...

Fancamp Announces Receipt of Extension Notice of Maturity Date of Secured Convertible Promissory Note

Written by Customer Service on March 2, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) announced today that Fancamp has received notice from The Canadian Chrome Company Inc. (formerly KWG Resources Inc.) (“CCC”) of the exercise of its one-time option to extend the maturity date of the secured convertible promissory note dated September 1, 2022 issued by CCC in favour of Fancamp. The maturity date of the secured convertible promissory note will be extended from September 1, 2026 to August 31, 2027, provided there is no event of default under the secured convertible promissory note on or before September 1, 2026. About Secured Convertible Promissory Note As previously announced, Fancamp agreed to sell its beneficial interests in the Koper Lake-McFaulds mining claims located...

Navigator Gas Announces Signing of $133.7 Million Secured Term Loan For Financing of Two Newbuild Vessels

Written by Customer Service on March 2, 2026. Posted in Public Companies.

LONDON, March 02, 2026 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (“Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, is pleased to announce that today, its subsidiaries, Navigator Parsec L.L.C. and Navigator Pleione L.L.C. (the “Borrowers”), entered into a senior secured pre- and post-delivery term loan (the “Facility Agreement”) with ABN AMRO Bank N.V., Crédit Agricole Corporate & Investment Bank and Nordea Bank Abp, filial i Norge (together, the “Lenders”), pursuant to which the Lenders have agreed to make available to the Borrowers up to $133,770,000, subject to the terms and conditions set out in the Facility Agreement. The loan will be used to finance up to 65% of the Borrowers’ payments of the pre-delivery and delivery instalments...

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Day: March 2, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals